The human XY gonadal sex reversal is a rare disease. Primary amenorrhea, lack of secondary sexual characteristics and the possible existence of streak gonads are the most common signs of this syndrome. Five cases of this syndrome have been described in the last 42 years in bovines. However, to the knowledge of the authors, no similar descriptions are available in sheep. In the present report, we are presenting the case of a 4 year old ewe 2n = 54,XY showing primary sterility and total absence of masculinization signs. The promoter and the complete coding segment of the sex determining region Y (SRY) were sequenced and found to be absolutely normal. The presence of the testis-specific protein gene (TSPY) was also verified by means of PCR. Necropsy findings include short vagina, lack of uterus and complete absence of masculine remains. Streak gonads concordant with previous descriptions in humans were also found.

Keywords:
Female XY Sex Reversal Syndrome, Normal SRY Sequence, Sheep
1.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402 (1997).
2.
Baylis MS, Wayte DM, Owen JB: An XO/XX mosaic sheep with associated gonadal dysgenesis. Res Vet Sci 36:125–126 (1984).
3.
Espiner EA, Veale AM, Sands VE, Fitzgerald PH: Familial syndrome of streak gonads and normal male karyotype in five phenotypic females. New Eng. J Med 283:6–11 (1970).
4.
Hare JE, Baird JD, Duignan P, Saunders J, Floetenmeyer R, Basrur PK: XY gonadal dysgenesis and tetralogy of Fallot in an Angus calf. Can Vet J 35:510–512 (1994).
6.
Henricson B, Akesson A: Two heifers with gonadal dysgenesis and the sex chromosomal constitution XY. Acta Vet Scand 8:262–272 (1967).
7.
Kawakura K, Miyake YI, Murakami RK, Kondoh S, Hirata TI, Kaneda Y: Deletion of the SRY region on the Y chromosome detected in bovine gonadal hypoplasia (XY female) by PCR. Cytogenet Cell Genet 72:183–184 (1996).
8.
Kawakura K, Miyake YI, Murakami RK, Kondoh S, Hirata TI, Kaneda Y: Abnormal structure of the Y chromosome detected in bovine gonadal hypoplasia (XY female) by FISH. Cytogenet Cell Genet 76:36–38 (1997).
9.
Kondoh S, Miyake Y, Nakahori Y, Nakagome Y, Kaneda Y: Cytogenetical and molecular biological studies on a bovine XY female. J Vet Med Sci 54:1077–1080 (1992).
10.
Macmillan KL, Fielden ED, McNatty KP, Henderson HV: LH concentrations in two cattle with XY gonadal dysgenesis. J Reprod Fertil 71:525–531 (1984).
11.
Michala L, Goswami D, Creighton SM, Conway GS: Swyer syndrome: presentation and outcomes. BJOG 115:737–741 (2008).
12.
OMIM: On Line Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim (consulted March 24, 2009).
13.
Orphanet Report Series: Rare Diseases collection. Prevalence of rare disease: Bibliographic data. Listed in alphabetical order of diseases. Number 1 (2008). http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf (consulted March 24, 2009).
14.
Payen EJ, Cotinot CY: Sequence evolution of SRY gene within Bovidae family. Mamm Genome 5:723–725 (1994).
15.
Sharma AK, Vijaykumar NK, Khar SK, Verma SK, Nigam JM: XY gonadal dysgenesis in a heifer. Vet Rec 107:328–330 (1980).
16.
Vogel T, Schmidtke J: Structure and function of TSPY, the Y-chromosome gene coding for the ‘testis-specific protein’. Cytogenet Cell Genet 80:209–213 (1998).
17.
Vogel T, Borgmann S, Dechend F, Hecht W, Schmidtke J: Conserved Y-chromosomal location of TSPY in Bovidae. Chromosome Res 5:182–185 (1997).
18.
Wachtel SS, Koo GC, de la Chapelle A, Kallio H, Heyman JM, Miller OJ: H-Y antigen in 46,XY gonadal dysgenesis. Hum Genet 54:25–30 (1980).
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.